For manufacturers reporting adverse incidents with cardiac ablation catheters under the European vigilance system.

Document

Detail

MHRA’s guidance on when to report adverse incidents with cardiac ablation catheters was superseded by the European Commission’s guidance in November 2014.

You need to read this alongside the European Commission’s guidelines on the vigilance system for medical devices.